Missing agreement between the two IMMULITE® PSA assays

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 4, 2013, Pages

  Fischer, Kersten ^a   Theil, Gerit ^a   Hoda, Raschid ^a   Fornara, Paolo ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Method comparison; Prostate cancer; Prostatespecific antigen (PSA); Variation

Indexed keywords

BOVINE SERUM ALBUMIN; PHOSPHATE BUFFERED SALINE; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; CALIBRATION; CANCER PATIENT; HUMAN; IMMUNOASSAY; LETTER; LIMIT OF DETECTION; MEDICAL ETHICS; OUTPATIENT; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATECTOMY; STANDARD; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

CALIBRATION; DIAGNOSTIC ERRORS; HUMANS; IMMUNOASSAY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REAGENT KITS, DIAGNOSTIC;

EID: 84882273404     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0152     Document Type: Letter

References (10)

1. Stephan C, Kramer J, Meyer HA, Kristiansen G, Ziemert S, Deger S, et al. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies. Br J Urol Int 2007;99:1427-31.
2. Sokoll LJ, Rosenwald S, Lyons J, Elliott DJ, Chan DW. Is the WHO 90:10 prostate-specific antigen (PSA) first international reference standard really 90% á 1 -antichymotrypsin-bound PSA and 10% free PSA? Clin Chem 2011;57:1776-7.
3. Linnet K. Evaluation of regression procedures for method comparison studies. Clin Chem 1993;39:424-32.
4. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-60.
5. Semjonow A, Oberpenning F, Weining C, Schmid HP, Lein M, Fobker G, et al. Unterschiede zwischen PSA-Bestimmungsverfahren. In: Fornara P, Semjonow A, editors. PSA: Der Weg zum Befund. M ü nchen, Wien, New York: W. Zuckschwerdt Verlag, 2002.
6. Stephan C, Bangma C, Vignati G, Bartsch G, Lein M, Jung K, et al. 20-25% lower concentrations of total and free prostatespecific antigen (PSA) after calibration of PSA assays to the WHO reference materials-analysis of 1088 patients in four centers. Int J Biol Markers 2009;24:65-9.
7. Vignati G, Giovanelli L. Standardization of PSA measures: a reappraisal and an experience with WHO calibration of Beckman Coulter Access Hybritech total and free PSA. Int J Biol Markers 2007;22:295-301.
8. IMMULITE® PSA [package insert]. Llanberis, UK: Siemens Healthcare Diagnostics Products Ltd.; 2008.
9. IMMULITE® Third Generation PSA [package insert]. Llanberis, UK: Siemens Healthcare Diagnostics Products Ltd.; 2009.
10. Roddam AW, Rimmer J, Nickerson C, Ward AM. Prostate-specific antigen: bias and molarity of commercial assays for PSA in use in England. Ann Clin Biochem 2006;43:35-48